Routine gastric residual aspiration in preterm infants and the effect on reaching full feed

ISRCTN ISRCTN98322846
DOI https://doi.org/10.1186/ISRCTN98322846
Secondary identifying numbers HA-02-J-008
Submission date
19/12/2017
Registration date
15/01/2018
Last edited
22/06/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Enteral nutrition is a way to provide food through a tube placed in the nose, the stomach, or the small intestine. Gastric residual (GR) refers to the volume of fluid remaining in the stomach at a point in time during enteral nutrition feeding. It is routinely evaluated in preterm infants fed through a tube (routine GR aspiration). Not only there is no evidence to justify the use of the routine practice of GR aspiration, there is also no standard management of the GR. There are wide variations amongst neonatologists and between different neonatal intensive care units (NICUs) regarding the significance of the volume and color of the GR and the interval at which the GR should be checked. Nutrition in the NICU is considered one of the most challenging and important aspects of neonatal care to optimize the clinical outcomes of this fragile and at risk population. Routine GR aspiration can delay the achievement of full enteral feeding with its consequences of extra-uterine growth retardation, cholestasis and increased risk of sepsis. The aim of this study is to evaluate the effect of routine GR aspiration in preterm infants on reaching feed of 120cc/kg/day. It is thought that infants not receiving routine GR evaluation would reach a feed of 120cc/kg/day 3 days earlier than infants undergoing routine GR aspiration.

Who can participate?
Preterm infants at 32 weeks gestation or less

What does the study involve?
Participants are randomly allocated to one of two groups. Both groups strictly follow the feeding protocol as per the unit protocol. Infants in one group undergo routine gastric aspiration with pre-feeding aspiration every 6 hours. Infants in the other group proceed with feeding with no aspiration. Both groups strictly follow a scheme in case of having vomiting, abdominal distension or other GI symptoms. The number of days it takes to reach a feed of 120cc/kg/day is recorded. All infants are followed up until discharge.

What are the possible benefits and risks of participating?
Based on previous studies, patients not receiving routine GR aspiration may reach a full feed 6 days earlier and have fewer 6 days on central line. Possible risks include regurgitation and vomiting in the no aspiration group.

Where is the study run from?
King Abdulaziz University Hospital (Saudi Arabia)

When is the study starting and how long is it expected to run for?
December 2015 to December 2019

Who is funding the study?
King Abdulaziz University (Saudi Arabia)

Who is the main contact?
Dr Hala Aljariry
Haljariry@kau.edu.sa

Contact information

Dr Hala Aljariry
Scientific

Department of Pediatrics
King Abdulaziz University
Jeddah
PO Box 80215 Jeddah 21589
Saudi Arabia

ORCiD logoORCID ID 0000-0002-7604-585X
Phone +966 (0)26401000 ext 20208
Email Haljariry@kau.edu.sa

Study information

Study designSingle-center unblinded randomized clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleRoutine gastric residual aspiration in preterm infants and the effect on reaching full feed: a randomized controlled trial
Study objectivesIt is hypothesized that infants not receiving routine gastric residual (GR) evaluation would reach feed of 120cc/kg/day 3 days earlier than infants undergoing routine GR aspiration.
Ethics approval(s)Research Ethics Committee at King Abdulaziz University, 20/12/2015, ref: 396-15
Health condition(s) or problem(s) studiedReaching full feed
InterventionPrior to the experiment, a pilot study of 40 subjects was ran to obtain the variance estimates needed in determining the sample size. With the existing feeding protocol in the unit, the average time for infants less than or equal to 32 weeks to reach 120 ml/kg/day of feeding was 12 days (SD 6 days). It is hypothesized that no routine gastric aspirate will decrease the number of days to reach 120 ml/kg/day by 3 days. One hundred and twenty six patients were required to have an 80% chance of detecting, as significant at the 5% level, a three day decrease in the number of days to reach 120 ml/kg/day of feeding in the no routine gastric aspirate group.

An independent researcher provided sequentially numbered, opaque and sealed allocation envelops using computer generated random numbers. The envelopes are kept in the NICU in a locked cabinet and it is the responsibility of the in-charge nurse in NICU to open the cabinet when a patients is identified to be included in the study and after obtaining an informed written consent from one of the parents.

Both groups will strictly follow the feeding protocol as per the unit protocol. Infants undergoing routine gastric aspiration will have pre-feeding aspiration every 6 hours. Infants in the no routine aspiration group will proceed with feeding with no aspiration and both groups will strictly follow a scheme in case of having vomiting, abdominal distension or other GI symptoms. The number of days till reaching feed of 120cc/kg/day will be documented. All infants will be followed up until discharge.
Intervention typeProcedure/Surgery
Primary outcome measureThe number of days until reaching feed of 120cc/kg/day
Secondary outcome measures1. The number of days until reaching feed of 150 cc/kg/day
2. The number of days on parenteral nutrition (from admission until the time of reaching full feed)
3. The number of days until the removal of central lines (from the day of insertion upon admission or afterward before reaching full feed until removal)
4. The incidence of sepsis, defined as positive blood culture, throughout the hospital stay until discharge
5. The incidence of necrotizing enterocolitis, based on Bell staging stage 2 or more, throughout the hospital stay until discharge
6. Growth parameters: weight measured at 7, 14 and 21 days to get the average of weight gain gm/kg/day
Overall study start date20/12/2015
Completion date01/12/2019

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants126
Total final enrolment126
Key inclusion criteriaPreterm infants equal or less than 32 weeks gestation
Key exclusion criteria1. Any proved or suspected chromosomal abnormalities
2. Any gastrointestinal tract abnormalities
3. Patients with hypoxic ischemic insult
Date of first enrolment11/04/2016
Date of final enrolment11/05/2019

Locations

Countries of recruitment

  • Saudi Arabia

Study participating centre

King Abdulaziz University Hospital
Jeddah
21589
Saudi Arabia

Sponsor information

King Abdulaziz University
University/education

PO Box 80215
Jeddah
21589
Saudi Arabia

Phone +966 (0)26401000 ext 20208
Email Haljariry@kau.edu.sa
ROR logo "ROR" https://ror.org/02ma4wv74

Funders

Funder type

University/education

King Abdulaziz University
Government organisation / Local government
Alternative name(s)
جامعة الملك عبدالعزيز, L'université du Roi Abdulaziz, La Universidad Rey Abdulaziz, King Abdulaziz University of Saudi Arabia, KAU
Location
Saudi Arabia

Results and Publications

Intention to publish date01/12/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high impact peer reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Dr Hala Aljariry (haljariry@kau.edu.sa). The data will be available once the recruitment is completed. SPSS for Windows, version 21.0 (SPSS, Chicago, IL, USA) is used. A written consent was taken from the parents and a copy was kept with them, an additional copy in the patients file and a copy with the investigator. No ethical or legal restrictions.

Editorial Notes

22/06/2023: The intention to publish date was changed from 01/12/2022 to 01/12/2023.
15/06/2022: The intention to publish date was changed from 01/06/2022 to 01/12/2022.
16/12/2021: The intention to publish date was changed from 01/12/2021 to 01/06/2022.
04/06/2021: The intention to publish date was changed from 01/06/2021 to 01/12/2021.
22/01/2021: The intention to publish date was changed from 01/12/2020 to 01/06/2021.
15/08/2019: The following changes were made:
1. The recruitment end date was changed from 01/07/2019 to 11/05/2019.
2. The total final enrolment number was added.
11/02/2019: The following changes were made:
1. The recruitment end date was changed from 15/01/2019 to 01/07/2019.
2. The overall trial end date changed from 15/03/2019 to 01/12/2019.
3. The intention to publish date was changed from 15/12/2019 to 01/12/2020.
13/11/2018: The following changes were made:
1. The recruitment end date was changed from 11/10/2018 to 15/01/2019.
2. The overall trial end date changed from 15/12/2018 to 15/03/2019.